Naprod Life Sciences Private Limited — Paclitaxel Exporter Profile
Indian Pharmaceutical Exporter · #15 for Paclitaxel · $1.1M export value · DGFT Verified
Naprod Life Sciences Private Limited is the #15 Indian exporter of Paclitaxel with $1.1M in export value and 70 verified shipments. Naprod Life Sciences Private Limited holds a 1.4% market share in Paclitaxel exports across 14 countries. The company exports 23 pharmaceutical products worth $18.7M across 4 therapeutic categories.
Naprod Life Sciences Private Limited — Paclitaxel Export Profile: Buyers & Destinations
Where Does Naprod Life Sciences Private Limited Export Paclitaxel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $396.7K | 12 | 42.0% |
| PHILIPPINES | $170.5K | 8 | 18.1% |
| EL SALVADOR | $102.0K | 4 | 10.8% |
| ETHIOPIA | $100.0K | 2 | 10.6% |
| KENYA | $53.2K | 4 | 5.6% |
| JAMAICA | $31.8K | 3 | 3.4% |
| ZIMBABWE | $29.1K | 6 | 3.1% |
| MYANMAR | $21.7K | 7 | 2.3% |
| INDONESIA | $13.7K | 2 | 1.5% |
| NAMBIA | $7.0K | 2 | 0.7% |
Naprod Life Sciences Private Limited exports Paclitaxel to 14 countries. The largest destination is SOUTH AFRICA accounting for 42.0% of Naprod Life Sciences Private Limited's Paclitaxel shipments, followed by PHILIPPINES (18.1%) and EL SALVADOR (10.8%). These destinations reflect Naprod Life Sciences Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Paclitaxel from Naprod Life Sciences Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OETHMAAN BIOSIMS (PTY) LTD | SOUTH AFRICA | $178.3K | 4 |
| MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $170.5K | 8 |
| OETHMAAN BIOSIMS (PTY) LTD. | SOUTH AFRICA | $159.2K | 5 |
| COMMERCIAL BANK OF ETHIOPIA | ETHIOPIA | $100.0K | 2 |
| GENIMVE PHARMA, S,A DE C,V | EL SALVADOR | $51.0K | 2 |
| GENIMVE PHARMA,S,A DE C,V | EL SALVADOR | $51.0K | 2 |
| OETHMAAN BIOSIMS PTY LTD | SOUTH AFRICA | $50.0K | 1 |
| RIPPLE PHARMACUTICALES LTD, | KENYA | $32.4K | 2 |
| RIPPLE PHARMACUTICALES LTD. | KENYA | $20.8K | 2 |
| CDS INTER COMMERCIAL SUPPLIES LIMIT | JAMAICA | $16.7K | 2 |
Naprod Life Sciences Private Limited supplies Paclitaxel to 29 buyers globally. The largest buyer is OETHMAAN BIOSIMS (PTY) LTD (SOUTH AFRICA), followed by MULTICARE PHARMACEUTICALS PHILIPPIN (PHILIPPINES) and OETHMAAN BIOSIMS (PTY) LTD. (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Paclitaxel Export Value and How Much Does Naprod Life Sciences Private Limited Contribute?
India exported $61.4M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. Naprod Life Sciences Private Limited contributes $1.1M to this total, accounting for 1.4% of India's Paclitaxel exports. Naprod Life Sciences Private Limited ships Paclitaxel to 14 countries through 29 buyers.
What Is the Average Shipment Value for Naprod Life Sciences Private Limited's Paclitaxel Exports?
Naprod Life Sciences Private Limited's average Paclitaxel shipment value is $16.1K per consignment, based on 70 shipments totaling $1.1M. The largest destination is SOUTH AFRICA (42.0% of Naprod Life Sciences Private Limited's Paclitaxel exports).
How Does Naprod Life Sciences Private Limited Compare to Other Indian Paclitaxel Exporters?
Naprod Life Sciences Private Limited ranks #15 among 319 Indian Paclitaxel exporters with a 1.4% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($25.1M), MSN LABORATORIES PRIVATE LIMITED ($6.9M), INTAS PHARMACEUTICALS LIMITED ($5.9M). Naprod Life Sciences Private Limited processed 70 shipments to 14 destination countries.
What Paclitaxel Formulations Does Naprod Life Sciences Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOXAT 100 (PACLITAXEL INJECTION USP 100M | $150.0K | 3 |
| Paclitaxel Injection USP 30mg/5ml Pacli | $102.0K | 4 |
| PACLITAXEL INJECTION USP 100MG 16 67ML PACLITAXEL INJECTION USP 100MG 16 67ML 14700 VIALS | $100.0K | 2 |
| Napro-Tax 260mg/43.34ml Paclitaxel Injec | $64.0K | 2 |
| LOXAT 100 PACLITAXEL INJECTION USP 100MG 16 67ML 7302 VIALS | $50.0K | 1 |
| LOXAT 100 (PACLITAXEL INJECTION USP 100MG/16.67ML) (14479 VIALS)VLS | $50.0K | 1 |
| LOXAT 100 PACLITAXEL INJECTION USP100MG/16.67ML | $50.0K | 1 |
| LOXAT 100 (PACLITAXEL INJECTION USP 100MG/16.67ML) (7302 VIALS) | $50.0K | 1 |
| Napro-Tax 260mg/43.34ml Paclitaxel Inje | $32.7K | 1 |
| LOXAT 100 PACLITAXEL INJECTION USP 100MG/16.67ML | $28.4K | 1 |
Naprod Life Sciences Private Limited exports 62 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOXAT 100 (PACLITAXEL INJECTION USP 100M with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Paclitaxel to Key Markets
What Naprod Life Sciences Private Limited must comply with to export Paclitaxel to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Naprod Life Sciences Private Limited Compare to Nearest Paclitaxel Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | ACCURE LABS PRIVATE LIMITED | $1.6M | 33 | 1 | $50.0K |
| 13 | SP ACCURE LABS PRIVATE LIMITED | $1.3M | 66 | 9 | $19.0K |
| 15 | NAPROD LIFE SCIENCES PRIVATE LIMITED ★ | $1.1M | 70 | 14 | $16.1K |
| 11 | CIPLA LIMITED | $950.0K | 19 | 5 | $50.0K |
| 14 | NV REMEDIES PRIVATE LIMITED | $550.0K | 11 | 3 | $50.0K |
Naprod Life Sciences Private Limited ranks #15 among 319 Indian Paclitaxel exporters. Average shipment value of $16.1K compared to the market average of $192.6K. The closest competitors by value are ACCURE LABS PRIVATE LIMITED and SP ACCURE LABS PRIVATE LIMITED.
Which Indian Ports Ship Paclitaxel Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 830 | 16.8% |
| SAHAR AIR | 614 | 12.5% |
| DELHI AIR | 599 | 12.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 554 | 11.2% |
| HYDERABAD AIR | 186 | 3.8% |
| AHEMDABAD AIR | 183 | 3.7% |
| Bombay Air | 172 | 3.5% |
| HYDERABAD ACC (INHYD4) | 160 | 3.2% |
What Other Oncology Products Does Naprod Life Sciences Private Limited Export?
Naprod Life Sciences Private Limited also exports these oncology products. Each links to the detailed product page.
About Naprod Life Sciences Private Limited
Naprod Life Sciences Private Limited exports 23 products worth $18.7M. Beyond Paclitaxel, top products include Carboplatin, Fluorouracil, Oxaliplatin, Methotrexate, Gemcitabine. View the complete Naprod Life Sciences Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Naprod Life Sciences Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 70 individual customs records matching Naprod Life Sciences Private Limited exporting Paclitaxel, covering 62 formulations to 14 countries via 29 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Export Data from Naprod Life Sciences Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Naprod Life Sciences Private Limited's Paclitaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Naprod Life Sciences Private Limited
Full Company Profile →
23 products · $18.7M total trade · 4 categories
Paclitaxel Stats
Company Overview
Top Products by Naprod Life Sciences Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Naprod Life Sciences Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current shipment-level data, contact TransData Nexus.